Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EUS-guided CPN vs RFA for Pancreatic Cancer Pain
NCT04809935Phase 4Unknown
- Sponsor
- The University of Hong Kong
- Start
- Sep 2020
- Primary completion
- Jan 2024
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by The University of Hong Kong. Primary endpoint: Pain score at 4 weeks. Status: unknown.
Beyond the preview
Go deeper on NCT04809935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04809935.